HomeNewsBusinessEconomyExclusive | At halfway mark, FinMin confident of meeting FY22 fiscal deficit target

Exclusive | At halfway mark, FinMin confident of meeting FY22 fiscal deficit target

Officials told Moneycontrol that although expenditure may be higher than budgeted this year, the Centre’s fiscal position is ‘more than comfortable’ and there is enough firepower for further economic support to some sectors

September 27, 2021 / 15:16 IST
Story continues below Advertisement
Finance Ministry (Image: PTI)
Finance Ministry (Image: PTI)

With the first six months of 2021-22 almost over, senior economic policymakers are confident of meeting the fiscal deficit target for the year, encouraged by strong tax revenue and a broad-based recovery across most sectors following the second wave of Covid-19.

Finance Minister Nirmala Sitharaman had budgeted a fiscal deficit target of Rs 15.07 lakh crore, or 6.8 percent of nominal gross domestic product, for FY22. The fiscal deficit for FY21 was revised to Rs 18.49 lakh crore, or 9.5 percent of GDP, from a budget target of 7.96 lakh crore, or 3.5 percent of GDP.

Story continues below Advertisement

Although expenditure commitments are higher than budgeted, the Centre’s fiscal position is “more than comfortable” and there is even “firepower to spare in case we need to provide further economic support to some sectors,” a top policymaker told Moneycontrol

“Direct tax and goods and services tax collections have been very strong... we have seen strong recovery across sectors after the second wave, which is an encouraging sign that tax revenue will be healthy in the second half of the year as well,” a second official said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show